Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2010-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pbb.2010.05.018PMID 20580909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• REVIEW: Reward sensitivity: issues of measurement, and achieving consilience between human and animal phenotypes

  2010influential reference
• The mGluR5 Antagonist MTEP Dissociates the Acquisition of Predictive and Incentive Motivational Properties of Reward-Paired Stimuli in Mice

  2010cited by this paper
• Principles of laboratory assessment of drug abuse liability and implications for clinical development.

  2009cited by this paper
• Self-administration of drugs in animals and humans as a model and an investigative tool.

  2007cited by this paper
• REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

  2007cited by this paper
• Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats.

  2007cited by this paper
• The compulsion zone: a pharmacological theory of acquired cocaine self-administration.

  2006cited by this paper
• Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.

  2006influential reference
• Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats

  2006cited by this paper
• REVIEW: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview

  2006influential reference
• Heroin self-administration in rats under a progressive ratio schedule of reinforcement

  2005cited by this paper
• The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats.

  2005cited by this paper
• Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice

  2005cited by this paper
• Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.

  2004cited by this paper
• Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.

  2004cited by this paper
• Clinical Pharmacology of Tramadol

  2004cited by this paper
• Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.

  2004cited by this paper
• Guidelines and methodological reviews concerning drug abuse liability assessment.

  2003cited by this paper
• Involvement of AMPA Receptor GluR2 Subunits in Stimulus-Reward Learning: Evidence from Glutamate Receptor gria2 Knock-Out Mice

  2003cited by this paper
• A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats

  2003cited by this paper
• Selective Disruption of Stimulus-Reward Learning in Glutamate Receptor gria1 Knock-Out Mice

  2003cited by this paper
• Principles of drug abuse liability assessment in laboratory animals.

  2003influential reference
• In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol

  2002cited by this paper
• Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol.

  2002cited by this paper
• The pharmacokinetic determinants of the frequency and pattern of intravenous cocaine self-administration in rats by pharmacokinetic modeling.

  2002cited by this paper
• Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.

  2001cited by this paper
• Influence of tramadol on morphine discriminative behavior in rats.

  2000cited by this paper
• Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats

  2000influential reference
• Satiety threshold: a quantitative model of maintained cocaine self-administration.

  1999cited by this paper
• Associative Processes in Addiction and Reward The Role of Amygdala‐Ventral Striatal Subsystems

  1999cited by this paper
• Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

  1998cited by this paper
• Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review

  1998cited by this paper
• Drug discrimination in neurobiology.

  1998cited by this paper
• A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement.

  1997cited by this paper
• Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.

  1997cited by this paper
• The pharmacokinetics of remifentanil.

  1996cited by this paper
• Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

  1996cited by this paper
• Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl.

  1996cited by this paper
• Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration

  1995cited by this paper
• The neural basis of drug craving: an incentive-sensitization theory of addiction.

  1993cited by this paper
• D-16949 (anpirtoline): a novel serotonergic (5-HT1B) psychotherapeutic agent assessed by its discriminative effects in the rat.

  1992cited by this paper
• The reinforcing and subjective effects of morphine in post-addicts: a dose-response study.

  1991cited by this paper
• Drug abuse potential evaluation in animals.

  1991cited by this paper
• Animal models of drug withdrawal symptoms

  1990cited by this paper
• The Evaluation of the Abuse Liability of Drugs

  1990cited by this paper
• Models of relative reinforcing efficacy of drugs and their predictive utility.

  1990cited by this paper
• Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.

  1989cited by this paper
• Preclinical assessment of abuse liability of drugs

  1988cited by this paper
• Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat.

  1988cited by this paper
• Bupropion: clinical assay for amphetamine-like abuse potential.

  1983cited by this paper
• Progressive-ratio performance in the rhesus monkey maintained by opiate infusions

  1979cited by this paper
• Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys.

  1978influential reference
• A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys.

  1978cited by this paper
• A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys.

  1978cited by this paper
• Behavioral procedures for evaluating the relative abuse potential of CNS drugs in primates.

  1976cited by this paper

• Aspirin attenuates tramadol-induced conditioned place preference: involvement of cytokines, antioxidant enzymes, and apoptosis.

  2025cites this paper
• Preclinical abuse potential testing using behavioral economics and drug self-administration demand-curve analysis: A strategy to improve resolution of drug stratification for regulatory control.

  2025cites this paper
• A novel tramadol–polycaprolactone implant could palliate heroin conditioned place preference and withdrawal in rats: behavioral and neurochemical study

  2024cites this paper
• The role of lateral habenula NMDA receptors in tramadol-induced conditioning

  2023cites this paper
• Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving

  2023cites this paper
• Reinforcing effect of tramadol in the rat.

  2023cites this paper
• The role of cannabinoid 1 receptor in the nucleus accumbens on tramadol induced conditioning and reinstatement.

  2020cites this paper
• Preclinical assessment of tramadol abuse potential: Effects of acute and repeated tramadol on intracranial self-stimulation in rats

  2020cites this paper
• Revisiting Tramadol: A Multi-Modal Agent for Pain Management

  2019cites this paper
• Discriminative Stimulus and Low Abuse Liability Effects of Novel Endomorphin Analogs Suggest a Potential Treatment Indication for Opioid Use Disorder

  2019cites this paper
• Punishment and reinforcement by opioid receptor agonists in a choice procedure in rats

  2019cites this paper
• Tramadol induces changes in Δ-FosB, µ-opioid receptor, and p-CREB level in the nucleus accumbens and prefrontal cortex of male Wistar rat

  2019cites this paper
• Enhanced Recovery Protocol for Laparoscopic Sleeve Gastrectomy: Are Narcotics Necessary?

  2019cites this paper
• An institutional intervention to modify opioid prescribing practices after lumbar spine surgery.

  2019cites this paper
• OF TRAMADOL ABUSE

  2018cites this paper
• Cross state-dependency of learning between tramadol and MK-801 in the mouse dorsal hippocampus: involvement of nitric oxide (NO) signaling pathway

  2018cites this paper
• Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial

  2017cites this paper
• In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential

  2017cites this paper
• Tramadol Abuse and Sexual Function.

  2016cites this paper
• Tramadol, Usage, Misuse, and Addiction Processes

  2016cites this paper
• Utility of Intracranial Self-Stimulation in the Assessment of the Abuse Liability of New Pharmaceuticals

  2015cites this paper
• Tramadol in Palliative Care #290

  2015cites this paper
• Pharmacometrics in Pain Management

  2014cites this paper
• Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery

  2014cites this paper
• Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats.

  2014cites this paper
• Pharmacological Investigation of NOP-Related Ligands as Analgesics without Abuse Liability

  2013cites this paper
• A translational pharmacology approach to understanding the predictive value of abuse potential assessments

  2013cites this paper
• The Investigation of Tramadol Dependence with No History of Substance Abuse: A Cross-Sectional Survey of Spontaneously Reported Cases in Guangzhou City, China

  2013cites this paper
• A proactive nonclinical drug abuse and dependence liability assessment strategy: a sponsor perspective

  2013cites this paper
• Abuse liability and reinforcing efficacy of oral tramadol in humans.

  2013cites this paper
• Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine.

  2012cites this paper
• Designing Opioids That Deter Abuse

  2012cites this paper
• Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations.

  2012cites this paper
• Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment

  2012cites this paper
• Discriminative Stimulus Effects of Tramadol in Humans

  2011cites this paper
• Endogenous opiates and behavior: 2010.

  2011cites this paper